With the amalgamation of peerless speakers, Meetings International is privileged to announce its “ 3rd International Conference on Genetic Engineering” which will be held during May 24-25, 2023 in London, UK. We cordially invite all the eminent scientists, research scholars, notable geneticists, educationists, professionals, and students to witness invaluable scientific discussions and contribute to future innovations in the field of Genetic Engineering.
Genetic Engineering Conference will focus on the latest and exciting innovations in all areas of Genetic Engineering and its research, as well as the relentless efforts made by scientists and scholars to improve the existing knowledge and invent novel technologies for the future. This year’s conference highlights the theme “Emerging challenges and developments in the field of genetics”, which reflects the different features of Genetic Engineering and its innovative progress in research. The two-day conference includes symposiums, workshops, and special keynote sessions conducted by eminent and profound speakers who excel in the field of Genetic Engineering, Recombinant DNA Technology, CRISPR-Cas 9 Technology, Immunotherapy, Gene editing and Genotyping, application in Agriculture, Medical, and Industries, futuristic approach and novel discoveries relating to Genetic Engineering and Business analysis.
Session1: Recombinant DNA Technology
As of June 2018, approximately 9 out of every 10 acres of sugar beets, cotton, corn, canola and soybeans grown in the United States were cultivated using genetically engineered seeds; around 80% of U.S. corn and 82% of the cotton estate was planted with seeds that were genetically modified.
Genetic Engineering Conferences | CRISPR-Cas9 Conferences | Genotyping Conferences | Genome Editing conferences | Genetic Engineering Conferences
Session 2: Genome Editing
A technique widely used to bring changes in physical traits like eye colour, to reduce the risk of diseases, etc. It targets genetic modifications enabling knockout and addition of specific genes. About seven in ten people (72%) worldwide react positively to changing an unborn baby’s genetic characteristics to treat some severe genetic disorders, whereas 21%-30% of people consider this taking the technology too far.
Genetic Engineering Conferences | CRISPR-Cas9 Conferences | Genotyping Conferences | Genome Editing conferences | Genetic Engineering Conferences
Session 3: Genotyping
Genotyping is the process of determining the DNA sequences and determining the difference in genetic makeup of organisms. It has a very high scope in Biomedical research, clinics, agriculture etc. To determine the genes relevant to specific traits or diseases, different Sequence variations can be used as markers in linkage and in association studies. In 2019, more than 1 million SNPs were genotyped using different genotyping platforms.
Genetic Engineering Conferences | CRISPR-Cas9 Conferences | Genotyping Conferences | Genome Editing conferences | Genetic Engineering Conferences
Session 4: Use in Immunotherapy
Genetically engineered T cell immunotherapies have provided remarkable clinical success to treat B cell acute lymphoblastic leukemia by harnessing a patient's own T cells to kill cancer, and these approaches have the potential to provide therapeutic benefits for numerous other cancers, infectious diseases, and autoimmunity. The response rates for immunotherapy in treating cancer patients are 15-20%
Genetic Engineering Conferences | CRISPR-Cas9 Conferences | Genotyping Conferences | Genome Editing conferences | Genetic Engineering Conferences
Session 5: CRISPR-Ca9 Technology
CRISPR-Cas9 was adapted from a naturally occurring genome editing system in bacteria. The bacteria uses Cas9 or a similar enzyme to cut the DNA apart. CRISPR and CRISPR associated Cas -9 market size is valued at USD 1.42 billion in 2019 and is expected to grow at a compound annual growth rate of 16.6% from 2020 to 2027.
Genetic Engineering Conferences | CRISPR-Cas9 Conferences | Genotyping Conferences | Genome Editing conferences | Genetic Engineering Conferences
Session 6: Gene therapy and Cas-9 mediated suicide gene for MSC-based cancer gene therapy
Growing evidences revealed that MSC retain unique immunological features that are relevant for the treatments of immune-related disorders.The global gene therapy market is expected to grow from USD 3.8 billion in 2019 to USD 13.0 billion by 2024, at a CAGR of 27.8%.
Genetic Engineering Conferences | CRISPR-Cas9 Conferences | Genotyping Conferences | Genome Editing conferences | Genetic Engineering Conferences
Session 7: Use in Industrial Biotechnology
Genetic engineering has applications in medicine, research, industry, and agriculture and can be used on a wide range of plants, animals and microorganisms. Industrial applications include transforming microorganisms such as bacteria or yeast, or insect mammalian cells with a gene coding for a useful protein.
Genetic Engineering Conferences | CRISPR-Cas9 Conferences | Genotyping Conferences | Genome Editing conferences | Genetic Engineering Conferences
Session 8: Genetic engineering is a Bane or Boon
Genetic engineering is one such boon for humankind, as it has become a tool for improvement and treatment. GMO crops remain a topic of discussion. However the GMO crop market will grow compounded at a growth rate of 3.2% by the end of 2021. The production of genetically modified crops will increase from 112million tons in 2015 to 130million tons in the year 2021.
Genetic Engineering Conferences | CRISPR-Cas9 Conferences | Genotyping Conferences | Genome Editing conferences | Genetic Engineering Conferences
SCOPE & IMPORTANCE:
Genetic engineering is a significant tool for scientists. Genes and other genetic evidence from a wide range of organisms are converted into bacteria, creating genetically modified bacteria in the procedure. The introduction of new DNA does not require the usage of classical genetic methods; however traditional breeding methods are typically used for the proliferation of recombinant organisms. An organism that is produced through the introduction of recombinant DNA is known to be a genetically modified organism. The first organisms genetically engineered were bacteria in 1973 and then mice in 1974.
Genetic Engineering is getting importance because of its use in different arenas. In medicine genetic engineering has been used to mass-produce insulin, human growth hormones, follistim (for treating infertility), human albumin, monoclonal antibodies, antihemophilic factors, vaccines and many other drugs.
GLOBAL GENE EDITING MARKET:
Gene Editing Market size valued at USD 3.8 billion in 2019 and is expected to witness 14.9% CAGR from 2020 to 2026. Increasing advancements in gene editing technologies are anticipated to boost the market demand.
WHY TO ATTEND:
Growing awareness regarding availability of genetically modified crops and animals will have positive impact on the overall market revenue. Growing utilization of synthetic genes in incorporating newer biosynthetic pathway in microorganisms to manufacture biologics will escalate the market growth.
Scientific communities are considering gene editing tools such as CRISPR to potentially disrupt the SARS-CoV-2 genome, the virus that causes COVID-19.
This is anticipated to create growth opportunities for the businesses to invest in the gene editing market. In June 2020, Stanford University developed gene editing tool that destroys COVID-19 inside human cells. The tool is called PAC-MAN (Prophylactic Antiviral CRISPR in human cells). Development of such new and innovative gene editing approaches will fuel the market expansion.
FUNDING:
Improved funding for genetic research in developed regions including North America will drive the gene editing industry growth. The U.S. government capatalizes various research programs that facilitate the process of drug discovery for several rare genetic diseases. The National Institutes of Health (NIH), a principal agency of the U.S. government is accountable for research in genetics and biomedical and grants billions of dollars in funding. Research accomplishments for drug discovery increase the preference for gene editing performances. Also, recently developed remedies and drugs used in treatment of genetic diseases have reduced the mortality rates that will positively impact the industry size. The CRISPR-Cas9 section will spectate more than 15% growth rate during the period. Rising demand for CRISPR-Cas9 in varying the genome of organisms to develop commercially achievable products will accelerate the market demand. Also, CRISPR technology is simple, easy to use, and inexpensive unlike the other gene editing techniques such as TALENs, thus, increasing its adoption rate. Key market performers such as Thermo Fisher Scientific, Caribou Biosciences ,Takara Bio, are focusing on R&D activities for adding inventions in the CRISPR-Cas9 technology that has elevated inclination in research processes.
The pharma and biotech companies segment controlled around 46% gene editing market share in 2019 owing to grow focus of biotech companies on developing advanced gene editing technologies. Technological advancements in gene editing enable market performers to progress advanced technologies that are effective enough in treatment of a specific genetic disease as compared to the predictable therapies.
Meetings International is announcing the Young Scientist Awards through the International Genetic engineering Conference which is scheduled on May 24-25, 2023 in London, Uk. This Genetic Engineering conference focuses on "Emerging new challenges and development in genetics".
Genetic engineering and upcoming conferences will distinguish participants who have significantly added value to the scientific community of Genetic Engineering and provide them with exceptional Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researchers by meeting experts to exchange and share their experiences at our international conferences.
Genetic Engineering focuses mainly on the current research in the field of Genetics, CRISPR Technology, Gene editing, and Genotyping, their applications and future prospects. The genetic Engineering conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master's students, Ph.D. students and trainees to showcase their research and innovation.
Eligibility:
Young Scientists, faculty members, post-doctoral fellows, Ph.D. scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.
Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective areas by giving them a chance to present their achievements and future perspectives.
Acknowledgment as YRF Awardee.
Promotion on the conference website, Young Researcher Awards and certificates.
Link on the conference website.
Recognition on Meetings Int. Award Page.
Chance to coordinate with partners around the world.
Research work can be published in the relevant journal without any publication fee.
Criteria:
All presented abstracts will automatically be considered for the Award.
All the presentations will be evaluated in the conference venue.
All the awards will be selected by the judges of the award category.
The winners of the Young Scientist Award will receive an award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.
Guidelines:
All submissions must be in English.
The topic must fit into the scientific sessions of the conference.
Each individual participant is allowed to submit maximum of 2 papers.
The abstract must be submitted online as per the given abstract template.
Abstracts must be written in Times New Roman and font size will be 12
The abstract must contain the title, name, affiliation, country, speakers biography, recent photograph, image and reference
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication on the website, along with author permission. Failure to submit the PPT, and approval within the designated timeframe will result in forfeiture of the award.
Award Announcements:
The official announcement of the recipients will occur after the completion of the Genetic Engineering Conference
International Genetic Engineering Conference assists to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, includes banners, sponsored emails, article alerts or newsletters, which provides the clients with the very best customized marketing opportunities in science and medicine.
We are one of the renowned events organizing platform with most of eminent speakers and business audience form all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company.
If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3 million hits a month on our website, we have engaged audience including students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the domains.
If you sell research materials, products, Gene therapy related medicine, different genetic techniques, instruments, or other related services, here is your opportunity to advertise in the website that can connect you to leading experts and science specialists across the Globe.
Advertisement banner must be provided in high resolution jpg or jpeg format by the advertising company and must not have copyright infringement. We can also support your events and conferences by providing you with high quality reprints of published articles that can add value to your event.
For any queries regarding advertising opportunities, please contact:
Whatsapp Number : +65 31381626